MPC1: Mitochondrial Pyruvate Carrier 1
A key regulator of mitochondrial pyruvate import and metabolic reprogramming in health and disease
Gene Information Card
| Symbol | MPC1 |
|---|---|
| Full Name | Mitochondrial Pyruvate Carrier 1 |
| Gene Type | Protein coding |
| Chromosomal Location | 6q27 |
| NCBI Gene ID | 51660 ncbi.nlm.nih.gov/gene/51660 |
| Ensembl ID | ENSG00000112667 |
| UniProt ID | Q9Y6U8 |
| OMIM ID | 614738 |
| HGNC ID | 29193 |
| Aliases | BRP44L, CGI-129, dJ68L15.3, MPYCD, SLC54A1 |
Description
The MPC1 gene encodes the mitochondrial pyruvate carrier 1 protein, a subunit of the heterodimeric mitochondrial pyruvate carrier (MPC) complex. This complex is essential for the transport of pyruvate from the cytoplasm into the mitochondrial matrix, where it enters the tricarboxylic acid (TCA) cycle. MPC1 forms a functional complex with MPC2 to mediate pyruvate uptake, linking glycolysis to oxidative metabolism. Loss-of-function mutations in MPC1 cause mitochondrial pyruvate carrier deficiency, leading to lactic acidosis, developmental delay, and neurological impairment. Altered MPC1 expression is also implicated in cancer metabolism and metabolic disorders.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Mitochondrial pyruvate carrier deficiency (MPYCD) | Loss-of-function mutations in MPC1 impair pyruvate import into mitochondria, causing accumulation of lactate and metabolic acidosis. | OMIM #614741, ClinVar |
| Lactic acidosis | Defective MPC1 leads to impaired pyruvate oxidation and increased lactate production. | OMIM #614741, PubMed |
| Developmental delay and neurological impairment | MPC1 deficiency disrupts energy metabolism in the brain, leading to microcephaly, hypotonia, and psychomotor delay. | OMIM #614741, ClinVar |
| Cancer (various types) | Altered MPC1 expression affects metabolic reprogramming (Warburg effect) in tumors; reduced MPC1 promotes glycolysis. | COSMIC, PubMed |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Liver | 12.5 | Medium |
| Heart | 10.8 | Medium |
| Kidney | 9.2 | Medium |
| Brain | 7.1 | Medium |
| Skeletal muscle | 6.5 | Low |
| Pancreas | 5.3 | Low |
| Lung | 4.8 | Low |
| Adipose tissue | 3.2 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HepG2 (liver) | 14.3 | High expression |
| K562 (leukemia) | 8.7 | Medium expression |
| HeLa (cervical) | 6.1 | Low expression |
| A549 (lung) | 5.4 | Low expression |
| MCF7 (breast) | 4.2 | Low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.289G>A (p.Gly97Ser) | Missense | Rare | Loss of function; associated with MPYCD |
| c.236T>C (p.Leu79Pro) | Missense | Rare | Loss of function; impaired pyruvate transport |
| c.181C>T (p.Arg61Trp) | Missense | Rare | Loss of function; reduced protein stability |
| c.1A>G (p.Met1Val) | Start loss | Rare | Loss of function; no protein production |
| c.424_425del (p.Gln142fs) | Frameshift | Rare | Loss of function; truncated protein |
Mutation functional classification
Loss of Function (LOF)
Most reported MPC1 mutations are loss-of-function, impairing pyruvate transport into mitochondria, leading to metabolic acidosis and neurological symptoms.
Gain of Function (GOF)
No gain-of-function mutations have been reported for MPC1.
Dominant Negative (DN)
No dominant-negative mutations have been described; MPC1 deficiency is typically autosomal recessive.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Pyruvate metabolism (KEGG: hsa00620)
• Citrate cycle (TCA cycle) (KEGG: hsa00020)
• Metabolic pathways (KEGG: hsa01100)
• Mitochondrial pyruvate carrier (Reactome: R-HSA-8949613)
Protein Summary
MPC1 is a 150-amino acid mitochondrial inner membrane protein that forms a heterodimeric complex with MPC2 to function as the mitochondrial pyruvate carrier. It contains two transmembrane domains and is essential for the import of pyruvate into the mitochondrial matrix. The protein is widely expressed, with highest levels in liver, heart, and kidney. Loss of MPC1 function disrupts the link between glycolysis and oxidative phosphorylation, leading to metabolic disorders and altered cancer cell metabolism.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| MPC1 Knockout HEK293 Cell Line | EDJ-KQ11177 | Human | 51660 | Details Get a Quote |
| MPC1L Knockout HEK293 Cell Line | EDJ-KQ14292 | Human | 347411 | Details Get a Quote |
| MPC1 Knockout A-549 Cell Line | EDJ-KQ39214 | Human | 51660 | Details Get a Quote |
| MPC1 Knockout HCT 116 Cell Line | EDJ-KQ39215 | Human | 51660 | Details Get a Quote |
| MPC1 Knockout HeLa Cell Line | EDJ-KQ39216 | Human | 51660 | Details Get a Quote |
| MPC1L Knockout HeLa Cell Line | EDJ-KQ59812 | Human | 347411 | Details Get a Quote |
| MPC1L Knockout A-549 Cell Line | EDJ-KQ68281 | Human | 347411 | Details Get a Quote |
| MPC1L Knockout HCT 116 Cell Line | EDJ-KQ76655 | Human | 347411 | Details Get a Quote |
Displaying Records 1 To 8 Of 8 Records